Covid Shot From China’s Clover Found 79% Effective Against Delta
Bloomberg News-
Chengdu firm says dose is 100% effective against severe Covid
-
China’s first shot to show clear efficacy data against delta
A vaccine developed by Sichuan Clover Biopharmaceuticals Inc. was found to prevent 79% of Covid-19 cases caused by the delta strain in late-stage trials, making it the first Chinese shot to offer clear efficacy data against the variant causing resurgent virus waves around the world.
The Clover candidate deploys protein on the coronavirus to stimulate immunity against Covid, an approach also used by the shot developed by Novavax Inc. It is 100% effective against severe Covid caused by any variants detected in the trial, including delta, gamma and mu, which first emerged from India, Brazil and Colombia respectively.
The company will apply for approval of the vaccine with regulators in China, the European Union and the World Health Organization in the fourth quarter of this year, and expects to roll out the shot by the end of 2021, Clover said in the statement.